Other featured articles
Who Wins When a Prescription Copay Exceeds the Drug Price? (Not the Patient)
Use an interactive graph to see how frequently a co-payment exceeds the price of commonly prescribed drugs and the average size of the overpayment.
Trump Might Actually Lower Drug Prices
Dana Goldman and Anupam Jena write in The Washington Post that the Trump administration may succeed in lowering drug prices by fostering competition and innovation, and possibly ending kickbacks in the supply chain.
Informing Clinicians of a Patient’s Fatal Overdose Changes Their Prescribing Behavior
When a clinician is given information about a patient’s fatal overdose caused by prescription opioids, they decrease their opioid prescribing.
The Leonard D. Schaeffer Center for Health Policy & Economics, one of the nation’s premier policy centers, measurably improves value in health through evidence-based policy solutions, research and educational excellence, and private- and public-sector engagement.about
Our Initiatives & Centers
Learn about our collaborative efforts to inform the national healthcare debate, mitigate the consequences of health disparities, and examine cost and accessibility of care.Learn More
Work & Study at USC
The Schaeffer Center develops innovators for positions in higher education, research, government and healthcare through degree programs and postgraduate opportunities.Learn More
A Conversation with Seema VermaThe USC-Brookings Schaeffer Initiative for Health Policy will host Seema Verma, the Administrator of CMS, for a discussion about Medicare Part D and what can be done to improve the program.Date of event:
Seminar Series: Chirantan ChatterjeeChirantan Chatterjee is an associate professor of business policy and economics at the Indian Institute of Management, Ahmedabad. His research focuses on the economics of innovation, applied microeconomics, pharmaceutical economics, and global health.Date of event:
Seminar Series: Toshiaki IizukaToshiaki Iizuka is a professor at the Graduate Schools of Economics and Public Policy at the the University of Tokyo. His research focuses on health economics and health policy, with an emphasis on incentives and information in healthcare markets.Date of event: